The efficacy of combination therapy to treat rheumatoid arthritis (RA) is currently the subject of many clinical trials. Intramuscular gold is one of the oldest disease-modifying antirheumatic drugs ...
rheumatoid arthritis Researchers from the University of Calgary found moderate to high quality evidence that triple therapy with methotrexate + sulfasalazine + hydroxycholoroquine or combining ...
Methotrexate is a primary disease-modifying anti-rheumatic drug (DMARD) used to treat rheumatoid arthritis (RA) by reducing inflammation and suppressing the immune system. The American College of ...
While a 1-year course of methotrexate improved physical function, pain, morning joint stiffness, and joint inflammation, it did not prevent the development of clinical arthritis. Among patients with ...
Methotrexate injection, a treatment for certain autoimmune diseases and cancers, can lead to various side effects. These range from common, mild reactions such as headache and nausea to serious, ...
Methotrexate is prescribed to at least 500,000 patients with rheumatoid arthritis (RA) worldwide; the best route of administration, however, is not clear. This multicenter, phase IV, randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results